Search Results
You are looking at 1 - 1 of 1 items for
- Author: Francesca Frigerio x
- Refine by access: All content x
Department of Cell Physiology and Metabolism, Animal Biology and Physiology, Organic Chemistry, Faculty of Medicine, University of Geneva, 1 rue Michel-Servet, 1211 Geneva 4, Switzerland Departments of
Search for other papers by Ivonne Gisèle Makom Ndifossap in
Google Scholar
PubMed
Search for other papers by Francesca Frigerio in
Google Scholar
PubMed
Search for other papers by Marina Casimir in
Google Scholar
PubMed
Search for other papers by Florence Ngueguim Tsofack in
Google Scholar
PubMed
Search for other papers by Etienne Dongo in
Google Scholar
PubMed
Search for other papers by Pierre Kamtchouing in
Google Scholar
PubMed
Search for other papers by Théophile Dimo in
Google Scholar
PubMed
Search for other papers by Pierre Maechler in
Google Scholar
PubMed
Sclerocarya birrea is a plant widely used as traditional medication for the treatment of diabetes in sub-Saharan regions. However, the mechanism of action is unknown and only hypoglycaemic effects of S. birrea extract (SBE) in diabetic rats have been reported to date. Here, we tested aqueous extracts of S. birrea on insulin-secreting INS-1E cells and isolated rat islets. Following 24 h of treatment at 5 μg/ml, the extract markedly potentiated glucose-stimulated insulin secretion. Neither basal insulin release nor non-nutrient stimulation was affected. The potentiation of the secretory response at stimulatory glucose appeared after 12 h of treatment. No acute effects were observed and, at the effective concentration, SBE was safe regarding cell integrity and differentiation. The mechanism of action of the SBE was related to glucose metabolism as both ATP generation and glucose oxidation were enhanced following the 24-h treatment. In streptozotocin-induced diabetic rats, SBE administration corrected glycaemia and restored plasma insulin levels after 2 weeks of treatment. These data show direct action of S. birrea on insulin-secreting cells and favour further delineation for use of the plant in the management of diabetes.